Novartis beats Q4 top-line and bottom-line estimates; initiates FY25 soft outlook

by


Close up image of wooden cubes with alphabet Q4 on office desk.

mohd izzuan

  • Novartis press release (NYSE:NVS): Q4 Non-GAAP EPS of $1.98 beats by $0.20.
  • Revenue of $13.15B (+15.1% Y/Y) beats by $330M.
  • Free cash flow from continuing operations amounted to $3.6 billion (+70% USD), compared with $2.1 billion in the prior-year quarter.


Leave a Comment